Clinical trial Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection
暂无分享,去创建一个
[1] B. Sangro,et al. [Treatment of chronic hepatitis B virus infection]. , 2004, Anales del sistema sanitario de Navarra.
[2] A. Lok,et al. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. , 1985, Journal of hepatology.
[3] S. Sherlock,et al. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. , 1983, Gut.
[4] M. Rizzetto,et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. , 1983, Annals of internal medicine.
[5] M. Rizzetto,et al. LONG-LASTING ABATEMENT OF HBsAg SYNTHESIS INDUCED BY ACUTE DELTA INFECTION , 1983, The Lancet.
[6] S. Sherlock,et al. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy. , 1983, Gut.
[7] K. Ishak,et al. Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis , 1982, Hepatology.
[8] S. Sherlock,et al. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). , 1982, Gut.
[9] S. Sherlock,et al. Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. , 1982, Gut.
[10] I. Murray-Lyon,et al. The clinical course of acute type A hepatitis in chronic HBsAg carriers—a report of 3 cases , 1982, Postgraduate medical journal.
[11] H. Thomas,et al. The detection of hbv‐dna in serum by molecular hybridisation: A more sensitive method for the detection of complete hbv particles , 1982, Journal of medical virology.
[12] J. Gerin,et al. An assay for the detection of the dna genome of hepatitis b virus in serum , 1982, Journal of medical virology.
[13] T. Merigan,et al. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. , 1981, Gastroenterology.
[14] I. Murray-Lyon,et al. NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERS Survey of 100 Patients from Great Britain , 1981, The Lancet.
[15] T. Merigan,et al. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. , 1981, The Journal of infectious diseases.
[16] S. Sherlock,et al. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. , 1981, Gastroenterology.
[17] T. Merigan,et al. Antiviral treatment of chronic hepatitis B virus infection: Improvement in liver disease with interferon and adenine arabinoside , 1981, Hepatology.
[18] R. Purcell,et al. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. , 1980, The Journal of infectious diseases.
[19] P. Marion,et al. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Rugge,et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. , 1980, Gastroenterology.
[21] S. Sherlock,et al. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine. , 1978, British medical journal.
[22] T. Merigan,et al. Effect of vidarabine on chronic hepatitis B virus infection. , 1978, JAMA.
[23] H. F. Kaufman. Adenine Arabinoside: An Antiviral Agent , 1975 .